BIO, the Biotechnology Innovation Organization, is the largest advocacy association representing biotechnology companies, academic and research institutions, and related organizations across the United States and in 30 countries. BIO's mission is to drive a globally competitive biotech industry by promoting health equality, investing in diverse talent, and expanding opportunities for underrepresented groups in the bioeconomy.

BIO serves a wide range of clients, including biotech companies, state biotechnology groups, academic institutions, and research organizations. The organization operates in the biotechnology market, focusing on health, agriculture, and environmental sectors. BIO's business model revolves around membership fees, event sponsorships, and industry partnerships. The organization generates revenue through its extensive portfolio of events, such as the BIO International Convention, BIO CEO Investor Conference, and BIO IMPACT Digital, which facilitate business development and investment in biotech innovation.

BIO also provides industry analysis reports, economic development best practices, and member savings programs, such as discounts on lab supplies. By advocating for policies that support biotech innovation and providing leadership in areas like workforce development, diversity, and inclusion, BIO ensures that biotech advancements reach patients efficiently and equitably.

Keywords: biotech advocacy, workforce development, diversity inclusion, industry events, health equality, biotech innovation, economic development, member savings, policy support, global community.